nodes	percent_of_prediction	percent_of_DWPC	metapath
Atropine—CYP1A2—Carmustine—melanoma	0.228	0.417	CbGbCtD
Atropine—CYP1A2—Vemurafenib—melanoma	0.18	0.33	CbGbCtD
Atropine—CYP1A2—Dacarbazine—melanoma	0.138	0.253	CbGbCtD
Atropine—Rash papular—Vemurafenib—melanoma	0.0101	0.0421	CcSEcCtD
Atropine—Cocaine—SCN11A—melanoma	0.00791	0.678	CrCbGaD
Atropine—Hyperaemia—Carmustine—melanoma	0.00656	0.0275	CcSEcCtD
Atropine—Electrocardiogram QT prolonged—Vemurafenib—melanoma	0.00584	0.0244	CcSEcCtD
Atropine—Paralysis—Vemurafenib—melanoma	0.00539	0.0226	CcSEcCtD
Atropine—Rash maculo-papular—Vemurafenib—melanoma	0.00341	0.0143	CcSEcCtD
Atropine—Visual acuity reduced—Temozolomide—melanoma	0.00322	0.0135	CcSEcCtD
Atropine—Sinus tachycardia—Docetaxel—melanoma	0.00316	0.0132	CcSEcCtD
Atropine—Cocaine—SCN10A—melanoma	0.00298	0.255	CrCbGaD
Atropine—Paranoia—Carmustine—melanoma	0.00291	0.0122	CcSEcCtD
Atropine—Atrial fibrillation—Vemurafenib—melanoma	0.00287	0.012	CcSEcCtD
Atropine—Stupor—Carmustine—melanoma	0.00265	0.0111	CcSEcCtD
Atropine—Dry skin—Vemurafenib—melanoma	0.00249	0.0104	CcSEcCtD
Atropine—Petechiae—Temozolomide—melanoma	0.00233	0.00974	CcSEcCtD
Atropine—Speech disorder—Carmustine—melanoma	0.0023	0.00964	CcSEcCtD
Atropine—Speech disorder—Temozolomide—melanoma	0.00223	0.00932	CcSEcCtD
Atropine—Skin exfoliation—Bleomycin—melanoma	0.00217	0.00907	CcSEcCtD
Atropine—Leukocytosis—Carmustine—melanoma	0.00211	0.00882	CcSEcCtD
Atropine—Injection site reaction—Carmustine—melanoma	0.00197	0.00824	CcSEcCtD
Atropine—Respiratory failure—Temozolomide—melanoma	0.00195	0.00816	CcSEcCtD
Atropine—Supraventricular tachycardia—Docetaxel—melanoma	0.00194	0.00813	CcSEcCtD
Atropine—Depressed level of consciousness—Carmustine—melanoma	0.00191	0.00801	CcSEcCtD
Atropine—Skin exfoliation—Carmustine—melanoma	0.00189	0.00792	CcSEcCtD
Atropine—Heartburn—Docetaxel—melanoma	0.00185	0.00774	CcSEcCtD
Atropine—Haemoglobin decreased—Docetaxel—melanoma	0.00185	0.00774	CcSEcCtD
Atropine—Depressed level of consciousness—Temozolomide—melanoma	0.00185	0.00774	CcSEcCtD
Atropine—Disorientation—Bleomycin—melanoma	0.00184	0.00771	CcSEcCtD
Atropine—Skin exfoliation—Temozolomide—melanoma	0.00183	0.00765	CcSEcCtD
Atropine—Coma—Carmustine—melanoma	0.00181	0.00758	CcSEcCtD
Atropine—Dry eye—Temozolomide—melanoma	0.00177	0.0074	CcSEcCtD
Atropine—Rash erythematous—Docetaxel—melanoma	0.00166	0.00696	CcSEcCtD
Atropine—Erythema—Vemurafenib—melanoma	0.00164	0.00686	CcSEcCtD
Atropine—Swelling—Carmustine—melanoma	0.00163	0.00682	CcSEcCtD
Atropine—Dysgeusia—Vemurafenib—melanoma	0.0016	0.00671	CcSEcCtD
Atropine—Eye pain—Carmustine—melanoma	0.00159	0.00667	CcSEcCtD
Atropine—Ageusia—Docetaxel—melanoma	0.00157	0.00658	CcSEcCtD
Atropine—Lethargy—Dactinomycin—melanoma	0.00157	0.00656	CcSEcCtD
Atropine—Eye pain—Temozolomide—melanoma	0.00154	0.00644	CcSEcCtD
Atropine—Amnesia—Carmustine—melanoma	0.00153	0.00641	CcSEcCtD
Atropine—Nasal congestion—Temozolomide—melanoma	0.00153	0.00639	CcSEcCtD
Atropine—Amnesia—Temozolomide—melanoma	0.00148	0.00619	CcSEcCtD
Atropine—Thirst—Temozolomide—melanoma	0.00146	0.00611	CcSEcCtD
Atropine—Hyponatraemia—Carmustine—melanoma	0.00144	0.00604	CcSEcCtD
Atropine—Ataxia—Carmustine—melanoma	0.00135	0.00566	CcSEcCtD
Atropine—Anaphylactic shock—Vemurafenib—melanoma	0.00134	0.0056	CcSEcCtD
Atropine—Dysphagia—Dactinomycin—melanoma	0.00133	0.00556	CcSEcCtD
Atropine—Hypokalaemia—Carmustine—melanoma	0.00131	0.00548	CcSEcCtD
Atropine—Ataxia—Temozolomide—melanoma	0.00131	0.00547	CcSEcCtD
Atropine—Respiratory failure—Docetaxel—melanoma	0.0013	0.00543	CcSEcCtD
Atropine—Dehydration—Temozolomide—melanoma	0.00129	0.00541	CcSEcCtD
Atropine—Dry skin—Temozolomide—melanoma	0.00127	0.00533	CcSEcCtD
Atropine—Blood pressure increased—Docetaxel—melanoma	0.00127	0.00533	CcSEcCtD
Atropine—Injection site reaction—Docetaxel—melanoma	0.00127	0.0053	CcSEcCtD
Atropine—Hypokalaemia—Temozolomide—melanoma	0.00127	0.00529	CcSEcCtD
Atropine—Acute coronary syndrome—Bleomycin—melanoma	0.00125	0.00524	CcSEcCtD
Atropine—Hypotension—Vemurafenib—melanoma	0.00125	0.00523	CcSEcCtD
Atropine—Myocardial infarction—Bleomycin—melanoma	0.00124	0.00521	CcSEcCtD
Atropine—Dysphagia—Carmustine—melanoma	0.00124	0.0052	CcSEcCtD
Atropine—Skin exfoliation—Docetaxel—melanoma	0.00122	0.00509	CcSEcCtD
Atropine—Abdominal distension—Temozolomide—melanoma	0.00121	0.00506	CcSEcCtD
Atropine—Dysphagia—Temozolomide—melanoma	0.0012	0.00503	CcSEcCtD
Atropine—Fatigue—Vemurafenib—melanoma	0.00115	0.00482	CcSEcCtD
Atropine—Constipation—Vemurafenib—melanoma	0.00114	0.00478	CcSEcCtD
Atropine—Pulmonary oedema—Docetaxel—melanoma	0.00113	0.00474	CcSEcCtD
Atropine—Dysuria—Temozolomide—melanoma	0.00112	0.0047	CcSEcCtD
Atropine—Hyperglycaemia—Carmustine—melanoma	0.00112	0.00469	CcSEcCtD
Atropine—Erectile dysfunction—Temozolomide—melanoma	0.00111	0.00463	CcSEcCtD
Atropine—Depression—Carmustine—melanoma	0.00111	0.00463	CcSEcCtD
Atropine—Hyperglycaemia—Temozolomide—melanoma	0.00108	0.00454	CcSEcCtD
Atropine—Depression—Temozolomide—melanoma	0.00107	0.00447	CcSEcCtD
Atropine—Flushing—Bleomycin—melanoma	0.00106	0.00443	CcSEcCtD
Atropine—Body temperature increased—Vemurafenib—melanoma	0.00106	0.00442	CcSEcCtD
Atropine—Swelling—Docetaxel—melanoma	0.00105	0.00439	CcSEcCtD
Atropine—Erythema—Bleomycin—melanoma	0.000992	0.00415	CcSEcCtD
Atropine—Hallucination—Carmustine—melanoma	0.00099	0.00414	CcSEcCtD
Atropine—Flushing—Dactinomycin—melanoma	0.000987	0.00413	CcSEcCtD
Atropine—Hypersensitivity—Vemurafenib—melanoma	0.000985	0.00412	CcSEcCtD
Atropine—Atrial fibrillation—Docetaxel—melanoma	0.000975	0.00408	CcSEcCtD
Atropine—Asthenia—Vemurafenib—melanoma	0.000959	0.00401	CcSEcCtD
Atropine—Hallucination—Temozolomide—melanoma	0.000957	0.004	CcSEcCtD
Atropine—Pruritus—Vemurafenib—melanoma	0.000946	0.00396	CcSEcCtD
Atropine—Lethargy—Docetaxel—melanoma	0.000943	0.00395	CcSEcCtD
Atropine—Hyponatraemia—Docetaxel—melanoma	0.000928	0.00388	CcSEcCtD
Atropine—Erythema—Dactinomycin—melanoma	0.000926	0.00387	CcSEcCtD
Atropine—Flushing—Carmustine—melanoma	0.000924	0.00387	CcSEcCtD
Atropine—Diarrhoea—Vemurafenib—melanoma	0.000915	0.00383	CcSEcCtD
Atropine—Flushing—Temozolomide—melanoma	0.000892	0.00374	CcSEcCtD
Atropine—Arrhythmia—Carmustine—melanoma	0.000889	0.00372	CcSEcCtD
Atropine—Dizziness—Vemurafenib—melanoma	0.000884	0.0037	CcSEcCtD
Atropine—Mental disorder—Carmustine—melanoma	0.000872	0.00365	CcSEcCtD
Atropine—Ataxia—Docetaxel—melanoma	0.000869	0.00364	CcSEcCtD
Atropine—Erythema—Carmustine—melanoma	0.000866	0.00363	CcSEcCtD
Atropine—Dehydration—Docetaxel—melanoma	0.00086	0.0036	CcSEcCtD
Atropine—Vomiting—Vemurafenib—melanoma	0.00085	0.00356	CcSEcCtD
Atropine—Dry skin—Docetaxel—melanoma	0.000847	0.00355	CcSEcCtD
Atropine—Chest pain—Bleomycin—melanoma	0.000845	0.00354	CcSEcCtD
Atropine—Rash—Vemurafenib—melanoma	0.000843	0.00353	CcSEcCtD
Atropine—Mental disorder—Temozolomide—melanoma	0.000842	0.00353	CcSEcCtD
Atropine—Dermatitis—Vemurafenib—melanoma	0.000842	0.00352	CcSEcCtD
Atropine—Headache—Vemurafenib—melanoma	0.000837	0.00351	CcSEcCtD
Atropine—Erythema—Temozolomide—melanoma	0.000837	0.0035	CcSEcCtD
Atropine—Dysgeusia—Temozolomide—melanoma	0.00082	0.00343	CcSEcCtD
Atropine—Confusional state—Bleomycin—melanoma	0.000817	0.00342	CcSEcCtD
Atropine—Vision blurred—Carmustine—melanoma	0.000816	0.00342	CcSEcCtD
Atropine—Anaphylactic shock—Bleomycin—melanoma	0.00081	0.00339	CcSEcCtD
Atropine—Oedema—Bleomycin—melanoma	0.00081	0.00339	CcSEcCtD
Atropine—Dysphagia—Docetaxel—melanoma	0.000799	0.00334	CcSEcCtD
Atropine—Agitation—Carmustine—melanoma	0.000796	0.00333	CcSEcCtD
Atropine—Nausea—Vemurafenib—melanoma	0.000794	0.00332	CcSEcCtD
Atropine—Vision blurred—Temozolomide—melanoma	0.000789	0.0033	CcSEcCtD
Atropine—Angina pectoris—Docetaxel—melanoma	0.000778	0.00326	CcSEcCtD
Atropine—Scopolamine—ABCB1—melanoma	0.000773	0.0663	CrCbGaD
Atropine—Agitation—Temozolomide—melanoma	0.000769	0.00322	CcSEcCtD
Atropine—Angioedema—Temozolomide—melanoma	0.000765	0.0032	CcSEcCtD
Atropine—Hypotension—Bleomycin—melanoma	0.000757	0.00317	CcSEcCtD
Atropine—Oedema—Dactinomycin—melanoma	0.000755	0.00316	CcSEcCtD
Atropine—Vertigo—Temozolomide—melanoma	0.000752	0.00315	CcSEcCtD
Atropine—Convulsion—Carmustine—melanoma	0.000751	0.00314	CcSEcCtD
Atropine—Palpitations—Temozolomide—melanoma	0.00074	0.0031	CcSEcCtD
Atropine—Chest pain—Carmustine—melanoma	0.000737	0.00309	CcSEcCtD
Atropine—Anxiety—Carmustine—melanoma	0.000735	0.00308	CcSEcCtD
Atropine—Convulsion—Temozolomide—melanoma	0.000725	0.00304	CcSEcCtD
Atropine—Dyspnoea—Bleomycin—melanoma	0.000722	0.00302	CcSEcCtD
Atropine—Confusional state—Carmustine—melanoma	0.000713	0.00298	CcSEcCtD
Atropine—Anxiety—Temozolomide—melanoma	0.00071	0.00297	CcSEcCtD
Atropine—Oedema—Carmustine—melanoma	0.000707	0.00296	CcSEcCtD
Atropine—Acute coronary syndrome—Docetaxel—melanoma	0.000702	0.00294	CcSEcCtD
Atropine—Myocardial infarction—Docetaxel—melanoma	0.000698	0.00292	CcSEcCtD
Atropine—Dry mouth—Temozolomide—melanoma	0.000697	0.00292	CcSEcCtD
Atropine—Pain—Bleomycin—melanoma	0.000693	0.0029	CcSEcCtD
Atropine—Conjunctivitis—Docetaxel—melanoma	0.000692	0.0029	CcSEcCtD
Atropine—Tachycardia—Carmustine—melanoma	0.00069	0.00289	CcSEcCtD
Atropine—Confusional state—Temozolomide—melanoma	0.000689	0.00288	CcSEcCtD
Atropine—Anaphylactic shock—Temozolomide—melanoma	0.000683	0.00286	CcSEcCtD
Atropine—Oedema—Temozolomide—melanoma	0.000683	0.00286	CcSEcCtD
Atropine—Feeling abnormal—Bleomycin—melanoma	0.000667	0.00279	CcSEcCtD
Atropine—Hypotension—Carmustine—melanoma	0.000661	0.00276	CcSEcCtD
Atropine—Hyperhidrosis—Temozolomide—melanoma	0.00066	0.00276	CcSEcCtD
Atropine—Fatigue—Dactinomycin—melanoma	0.000651	0.00273	CcSEcCtD
Atropine—Pain—Dactinomycin—melanoma	0.000646	0.0027	CcSEcCtD
Atropine—Urticaria—Bleomycin—melanoma	0.000643	0.00269	CcSEcCtD
Atropine—Body temperature increased—Bleomycin—melanoma	0.00064	0.00268	CcSEcCtD
Atropine—Insomnia—Carmustine—melanoma	0.000639	0.00268	CcSEcCtD
Atropine—Dyspnoea—Carmustine—melanoma	0.00063	0.00264	CcSEcCtD
Atropine—Somnolence—Carmustine—melanoma	0.000628	0.00263	CcSEcCtD
Atropine—Feeling abnormal—Dactinomycin—melanoma	0.000622	0.00261	CcSEcCtD
Atropine—Insomnia—Temozolomide—melanoma	0.000618	0.00259	CcSEcCtD
Atropine—Gastrointestinal pain—Dactinomycin—melanoma	0.000618	0.00259	CcSEcCtD
Atropine—Dyspnoea—Temozolomide—melanoma	0.000609	0.00255	CcSEcCtD
Atropine—Somnolence—Temozolomide—melanoma	0.000607	0.00254	CcSEcCtD
Atropine—Pain—Carmustine—melanoma	0.000605	0.00253	CcSEcCtD
Atropine—Constipation—Carmustine—melanoma	0.000605	0.00253	CcSEcCtD
Atropine—Dyspepsia—Temozolomide—melanoma	0.000601	0.00252	CcSEcCtD
Atropine—Abdominal pain—Dactinomycin—melanoma	0.000597	0.0025	CcSEcCtD
Atropine—Body temperature increased—Dactinomycin—melanoma	0.000597	0.0025	CcSEcCtD
Atropine—Hypersensitivity—Bleomycin—melanoma	0.000597	0.0025	CcSEcCtD
Atropine—Flushing—Docetaxel—melanoma	0.000594	0.00248	CcSEcCtD
Atropine—Fatigue—Temozolomide—melanoma	0.000589	0.00247	CcSEcCtD
Atropine—Pain—Temozolomide—melanoma	0.000584	0.00245	CcSEcCtD
Atropine—Constipation—Temozolomide—melanoma	0.000584	0.00245	CcSEcCtD
Atropine—Feeling abnormal—Carmustine—melanoma	0.000583	0.00244	CcSEcCtD
Atropine—Asthenia—Bleomycin—melanoma	0.000581	0.00243	CcSEcCtD
Atropine—Gastrointestinal pain—Carmustine—melanoma	0.000578	0.00242	CcSEcCtD
Atropine—Pruritus—Bleomycin—melanoma	0.000573	0.0024	CcSEcCtD
Atropine—Arrhythmia—Docetaxel—melanoma	0.000571	0.00239	CcSEcCtD
Atropine—Feeling abnormal—Temozolomide—melanoma	0.000563	0.00236	CcSEcCtD
Atropine—Mental disorder—Docetaxel—melanoma	0.00056	0.00234	CcSEcCtD
Atropine—Abdominal pain—Carmustine—melanoma	0.000559	0.00234	CcSEcCtD
Atropine—Body temperature increased—Carmustine—melanoma	0.000559	0.00234	CcSEcCtD
Atropine—Gastrointestinal pain—Temozolomide—melanoma	0.000559	0.00234	CcSEcCtD
Atropine—Erythema—Docetaxel—melanoma	0.000557	0.00233	CcSEcCtD
Atropine—Hypersensitivity—Dactinomycin—melanoma	0.000557	0.00233	CcSEcCtD
Atropine—Dysgeusia—Docetaxel—melanoma	0.000545	0.00228	CcSEcCtD
Atropine—Urticaria—Temozolomide—melanoma	0.000543	0.00227	CcSEcCtD
Atropine—Asthenia—Dactinomycin—melanoma	0.000542	0.00227	CcSEcCtD
Atropine—Body temperature increased—Temozolomide—melanoma	0.00054	0.00226	CcSEcCtD
Atropine—Abdominal pain—Temozolomide—melanoma	0.00054	0.00226	CcSEcCtD
Atropine—Hypersensitivity—Carmustine—melanoma	0.000521	0.00218	CcSEcCtD
Atropine—Diarrhoea—Dactinomycin—melanoma	0.000517	0.00216	CcSEcCtD
Atropine—Vomiting—Bleomycin—melanoma	0.000515	0.00216	CcSEcCtD
Atropine—Rash—Bleomycin—melanoma	0.000511	0.00214	CcSEcCtD
Atropine—Dermatitis—Bleomycin—melanoma	0.00051	0.00214	CcSEcCtD
Atropine—Asthenia—Carmustine—melanoma	0.000507	0.00212	CcSEcCtD
Atropine—Hypersensitivity—Temozolomide—melanoma	0.000503	0.00211	CcSEcCtD
Atropine—Syncope—Docetaxel—melanoma	0.000499	0.00209	CcSEcCtD
Atropine—Palpitations—Docetaxel—melanoma	0.000492	0.00206	CcSEcCtD
Atropine—Asthenia—Temozolomide—melanoma	0.00049	0.00205	CcSEcCtD
Atropine—Loss of consciousness—Docetaxel—melanoma	0.000489	0.00205	CcSEcCtD
Atropine—Diarrhoea—Carmustine—melanoma	0.000484	0.00202	CcSEcCtD
Atropine—Pruritus—Temozolomide—melanoma	0.000483	0.00202	CcSEcCtD
Atropine—Convulsion—Docetaxel—melanoma	0.000482	0.00202	CcSEcCtD
Atropine—Nausea—Bleomycin—melanoma	0.000481	0.00201	CcSEcCtD
Atropine—Vomiting—Dactinomycin—melanoma	0.00048	0.00201	CcSEcCtD
Atropine—Rash—Dactinomycin—melanoma	0.000476	0.00199	CcSEcCtD
Atropine—Chest pain—Docetaxel—melanoma	0.000474	0.00198	CcSEcCtD
Atropine—Dizziness—Carmustine—melanoma	0.000467	0.00196	CcSEcCtD
Atropine—Diarrhoea—Temozolomide—melanoma	0.000467	0.00196	CcSEcCtD
Atropine—Dry mouth—Docetaxel—melanoma	0.000464	0.00194	CcSEcCtD
Atropine—Confusional state—Docetaxel—melanoma	0.000458	0.00192	CcSEcCtD
Atropine—Oedema—Docetaxel—melanoma	0.000454	0.0019	CcSEcCtD
Atropine—Anaphylactic shock—Docetaxel—melanoma	0.000454	0.0019	CcSEcCtD
Atropine—Dizziness—Temozolomide—melanoma	0.000452	0.00189	CcSEcCtD
Atropine—Vomiting—Carmustine—melanoma	0.000449	0.00188	CcSEcCtD
Atropine—Nausea—Dactinomycin—melanoma	0.000449	0.00188	CcSEcCtD
Atropine—Shock—Docetaxel—melanoma	0.000447	0.00187	CcSEcCtD
Atropine—Rash—Carmustine—melanoma	0.000446	0.00187	CcSEcCtD
Atropine—Dermatitis—Carmustine—melanoma	0.000445	0.00186	CcSEcCtD
Atropine—Tachycardia—Docetaxel—melanoma	0.000443	0.00186	CcSEcCtD
Atropine—Headache—Carmustine—melanoma	0.000443	0.00185	CcSEcCtD
Atropine—Vomiting—Temozolomide—melanoma	0.000434	0.00182	CcSEcCtD
Atropine—Rash—Temozolomide—melanoma	0.000431	0.0018	CcSEcCtD
Atropine—Dermatitis—Temozolomide—melanoma	0.00043	0.0018	CcSEcCtD
Atropine—Headache—Temozolomide—melanoma	0.000428	0.00179	CcSEcCtD
Atropine—Hypotension—Docetaxel—melanoma	0.000425	0.00178	CcSEcCtD
Atropine—Nausea—Carmustine—melanoma	0.00042	0.00176	CcSEcCtD
Atropine—Insomnia—Docetaxel—melanoma	0.000411	0.00172	CcSEcCtD
Atropine—Nausea—Temozolomide—melanoma	0.000406	0.0017	CcSEcCtD
Atropine—Dyspnoea—Docetaxel—melanoma	0.000405	0.0017	CcSEcCtD
Atropine—Somnolence—Docetaxel—melanoma	0.000404	0.00169	CcSEcCtD
Atropine—Dyspepsia—Docetaxel—melanoma	0.0004	0.00167	CcSEcCtD
Atropine—Fatigue—Docetaxel—melanoma	0.000392	0.00164	CcSEcCtD
Atropine—Pain—Docetaxel—melanoma	0.000389	0.00163	CcSEcCtD
Atropine—Constipation—Docetaxel—melanoma	0.000389	0.00163	CcSEcCtD
Atropine—Feeling abnormal—Docetaxel—melanoma	0.000374	0.00157	CcSEcCtD
Atropine—Gastrointestinal pain—Docetaxel—melanoma	0.000372	0.00155	CcSEcCtD
Atropine—Abdominal pain—Docetaxel—melanoma	0.000359	0.0015	CcSEcCtD
Atropine—Body temperature increased—Docetaxel—melanoma	0.000359	0.0015	CcSEcCtD
Atropine—Hypersensitivity—Docetaxel—melanoma	0.000335	0.0014	CcSEcCtD
Atropine—Asthenia—Docetaxel—melanoma	0.000326	0.00136	CcSEcCtD
Atropine—Pruritus—Docetaxel—melanoma	0.000321	0.00135	CcSEcCtD
Atropine—Diarrhoea—Docetaxel—melanoma	0.000311	0.0013	CcSEcCtD
Atropine—Dizziness—Docetaxel—melanoma	0.0003	0.00126	CcSEcCtD
Atropine—Vomiting—Docetaxel—melanoma	0.000289	0.00121	CcSEcCtD
Atropine—Rash—Docetaxel—melanoma	0.000286	0.0012	CcSEcCtD
Atropine—Dermatitis—Docetaxel—melanoma	0.000286	0.0012	CcSEcCtD
Atropine—Headache—Docetaxel—melanoma	0.000285	0.00119	CcSEcCtD
Atropine—Nausea—Docetaxel—melanoma	0.00027	0.00113	CcSEcCtD
Atropine—CHRM3—Signaling Pathways—RAC1—melanoma	2.43e-05	0.000119	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.42e-05	0.000119	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL2—melanoma	2.42e-05	0.000119	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—PIK3CA—melanoma	2.41e-05	0.000118	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TERT—melanoma	2.41e-05	0.000118	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—RAC1—melanoma	2.4e-05	0.000118	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MDM2—melanoma	2.4e-05	0.000118	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—ERBB2—melanoma	2.37e-05	0.000116	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PPARG—melanoma	2.37e-05	0.000116	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GNA11—melanoma	2.35e-05	0.000115	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CB—melanoma	2.34e-05	0.000115	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HIF1A—melanoma	2.33e-05	0.000114	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HIF1A—melanoma	2.33e-05	0.000114	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—PIK3CA—melanoma	2.31e-05	0.000113	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HIF1A—melanoma	2.3e-05	0.000113	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MDM2—melanoma	2.3e-05	0.000113	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—FASN—melanoma	2.3e-05	0.000113	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—ERBB2—melanoma	2.27e-05	0.000111	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—SLC5A5—melanoma	2.26e-05	0.000111	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CXCL8—melanoma	2.24e-05	0.00011	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CB—melanoma	2.24e-05	0.00011	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KDR—melanoma	2.23e-05	0.000109	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—HRAS—melanoma	2.23e-05	0.000109	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KDR—melanoma	2.22e-05	0.000109	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KDR—melanoma	2.2e-05	0.000108	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1B—melanoma	2.19e-05	0.000108	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—GNAQ—melanoma	2.18e-05	0.000107	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CD44—melanoma	2.18e-05	0.000107	CbGpPWpGaD
Atropine—CHRM4—GPCR downstream signaling—AKT1—melanoma	2.17e-05	0.000106	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CD—melanoma	2.15e-05	0.000106	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CXCL8—melanoma	2.15e-05	0.000105	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CASP3—melanoma	2.15e-05	0.000105	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FN1—melanoma	2.15e-05	0.000105	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL2—melanoma	2.15e-05	0.000105	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FN1—melanoma	2.14e-05	0.000105	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—HRAS—melanoma	2.14e-05	0.000105	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.14e-05	0.000105	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—IL6—melanoma	2.13e-05	0.000105	CbGpPWpGaD
Atropine—CHRM3—Metabolism—ALB—melanoma	2.13e-05	0.000104	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FN1—melanoma	2.12e-05	0.000104	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—melanoma	2.12e-05	0.000104	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NOTCH1—melanoma	2.1e-05	0.000103	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1B—melanoma	2.1e-05	0.000103	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NOTCH1—melanoma	2.1e-05	0.000103	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CCND1—melanoma	2.09e-05	0.000103	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—CYP1B1—melanoma	2.09e-05	0.000103	CbGpPWpGaD
Atropine—CHRM5—GPCR downstream signaling—AKT1—melanoma	2.08e-05	0.000102	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NOTCH1—melanoma	2.07e-05	0.000102	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CTNNB1—melanoma	2.07e-05	0.000102	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CD80—melanoma	2.06e-05	0.000101	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CASP3—melanoma	2.06e-05	0.000101	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CG—melanoma	2.06e-05	0.000101	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KIT—melanoma	2.06e-05	0.000101	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—APC—melanoma	2.06e-05	0.000101	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—NRAS—melanoma	2.06e-05	0.000101	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL2—melanoma	2.05e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CD80—melanoma	2.05e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CG—melanoma	2.05e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—APC—melanoma	2.05e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KIT—melanoma	2.05e-05	0.000101	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—NRAS—melanoma	2.05e-05	0.000101	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—IL6—melanoma	2.04e-05	0.0001	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CD80—melanoma	2.03e-05	9.97e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGF—melanoma	2.03e-05	9.97e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MMP9—melanoma	2.03e-05	9.96e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CG—melanoma	2.03e-05	9.95e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—APC—melanoma	2.03e-05	9.95e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KIT—melanoma	2.03e-05	9.95e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—NRAS—melanoma	2.03e-05	9.95e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGF—melanoma	2.03e-05	9.94e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—CDKN1A—melanoma	2.02e-05	9.93e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PTEN—melanoma	2.02e-05	9.9e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NFKB1—melanoma	2.01e-05	9.86e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGF—melanoma	2.01e-05	9.84e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CCND1—melanoma	2e-05	9.83e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CTNNB1—melanoma	1.98e-05	9.73e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling by GPCR—AKT1—melanoma	1.97e-05	9.66e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—MAPK3—melanoma	1.97e-05	9.66e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—MAPK3—melanoma	1.96e-05	9.63e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MMP9—melanoma	1.94e-05	9.54e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—MAPK3—melanoma	1.94e-05	9.53e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—CDKN1A—melanoma	1.94e-05	9.5e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PTEN—melanoma	1.93e-05	9.48e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—BRAF—melanoma	1.93e-05	9.48e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—BRAF—melanoma	1.93e-05	9.45e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NFKB1—melanoma	1.92e-05	9.44e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—BRAF—melanoma	1.91e-05	9.36e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling by GPCR—AKT1—melanoma	1.89e-05	9.25e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IGF1—melanoma	1.88e-05	9.23e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CB—melanoma	1.88e-05	9.21e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IGF1—melanoma	1.88e-05	9.2e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—MAPK1—melanoma	1.87e-05	9.19e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—EGFR—melanoma	1.87e-05	9.19e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—MAPK1—melanoma	1.87e-05	9.16e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—EGFR—melanoma	1.87e-05	9.16e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTGS2—melanoma	1.86e-05	9.13e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IGF1—melanoma	1.86e-05	9.11e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—MAPK1—melanoma	1.85e-05	9.07e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—EGFR—melanoma	1.85e-05	9.07e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.85e-05	9.05e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—VEGFA—melanoma	1.82e-05	8.94e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAP2K1—melanoma	1.82e-05	8.92e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAP2K1—melanoma	1.81e-05	8.9e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CD—melanoma	1.81e-05	8.87e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—STAT3—melanoma	1.81e-05	8.86e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CD—melanoma	1.8e-05	8.84e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—NRAS—melanoma	1.8e-05	8.84e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAP2K1—melanoma	1.8e-05	8.81e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—PIK3CA—melanoma	1.79e-05	8.78e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—PIK3CA—melanoma	1.78e-05	8.75e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CD—melanoma	1.78e-05	8.75e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—KRAS—melanoma	1.77e-05	8.68e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—PIK3CA—melanoma	1.77e-05	8.67e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—KRAS—melanoma	1.76e-05	8.65e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—KRAS—melanoma	1.75e-05	8.57e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—VEGFA—melanoma	1.75e-05	8.57e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—FGF2—melanoma	1.73e-05	8.49e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—STAT3—melanoma	1.73e-05	8.48e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK3—melanoma	1.72e-05	8.46e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—FGF2—melanoma	1.72e-05	8.46e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—NRAS—melanoma	1.72e-05	8.46e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ABCB1—melanoma	1.72e-05	8.45e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—FGF2—melanoma	1.71e-05	8.38e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MYC—melanoma	1.68e-05	8.23e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK3—melanoma	1.65e-05	8.1e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—MAPK1—melanoma	1.64e-05	8.05e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—EGFR—melanoma	1.64e-05	8.05e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—PIK3CA—melanoma	1.63e-05	7.97e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PTEN—melanoma	1.62e-05	7.96e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—PIK3CA—melanoma	1.62e-05	7.95e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MDM2—melanoma	1.62e-05	7.94e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MDM2—melanoma	1.61e-05	7.92e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MYC—melanoma	1.61e-05	7.88e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—PIK3CA—melanoma	1.6e-05	7.87e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MDM2—melanoma	1.6e-05	7.84e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—ERBB2—melanoma	1.6e-05	7.83e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—ERBB2—melanoma	1.59e-05	7.81e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PRKCA—melanoma	1.58e-05	7.77e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—ERBB2—melanoma	1.58e-05	7.73e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CB—melanoma	1.58e-05	7.73e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ERCC2—melanoma	1.57e-05	7.71e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—MAPK1—melanoma	1.57e-05	7.71e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—EGFR—melanoma	1.57e-05	7.71e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CB—melanoma	1.57e-05	7.7e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CB—melanoma	1.55e-05	7.63e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—KRAS—melanoma	1.55e-05	7.6e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CXCL8—melanoma	1.51e-05	7.43e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CXCL8—melanoma	1.51e-05	7.4e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—HRAS—melanoma	1.5e-05	7.38e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—HRAS—melanoma	1.5e-05	7.35e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CXCL8—melanoma	1.49e-05	7.33e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—HRAS—melanoma	1.48e-05	7.28e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—KRAS—melanoma	1.48e-05	7.28e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1B—melanoma	1.48e-05	7.25e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1B—melanoma	1.47e-05	7.23e-05	CbGpPWpGaD
Atropine—CHRM1—GPCR downstream signaling—AKT1—melanoma	1.46e-05	7.17e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1B—melanoma	1.46e-05	7.16e-05	CbGpPWpGaD
Atropine—CHRM3—GPCR downstream signaling—AKT1—melanoma	1.46e-05	7.15e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CASP3—melanoma	1.45e-05	7.11e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL2—melanoma	1.45e-05	7.1e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CASP3—melanoma	1.44e-05	7.08e-05	CbGpPWpGaD
Atropine—CHRM2—GPCR downstream signaling—AKT1—melanoma	1.44e-05	7.08e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL2—melanoma	1.44e-05	7.07e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—IL6—melanoma	1.44e-05	7.06e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—IL6—melanoma	1.43e-05	7.04e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CASP3—melanoma	1.43e-05	7.02e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL2—melanoma	1.43e-05	7.01e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—PIK3CA—melanoma	1.42e-05	6.99e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—IL6—melanoma	1.42e-05	6.97e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CCND1—melanoma	1.41e-05	6.92e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CCND1—melanoma	1.41e-05	6.9e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CTNNB1—melanoma	1.4e-05	6.85e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CCND1—melanoma	1.39e-05	6.83e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CTNNB1—melanoma	1.39e-05	6.83e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CTNNB1—melanoma	1.38e-05	6.76e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—TP53—melanoma	1.38e-05	6.76e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MMP9—melanoma	1.37e-05	6.72e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MMP9—melanoma	1.36e-05	6.7e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—CDKN1A—melanoma	1.36e-05	6.69e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—PIK3CA—melanoma	1.36e-05	6.69e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PTEN—melanoma	1.36e-05	6.68e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—CDKN1A—melanoma	1.36e-05	6.67e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PTEN—melanoma	1.36e-05	6.66e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NFKB1—melanoma	1.35e-05	6.65e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MMP9—melanoma	1.35e-05	6.63e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NFKB1—melanoma	1.35e-05	6.62e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—CDKN1A—melanoma	1.35e-05	6.61e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PTEN—melanoma	1.34e-05	6.59e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NFKB1—melanoma	1.34e-05	6.56e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling by GPCR—AKT1—melanoma	1.33e-05	6.51e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling by GPCR—AKT1—melanoma	1.32e-05	6.49e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—TP53—melanoma	1.32e-05	6.47e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—HRAS—melanoma	1.32e-05	6.46e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling by GPCR—AKT1—melanoma	1.31e-05	6.43e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.3e-05	6.39e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—HRAS—melanoma	1.26e-05	6.19e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—IL6—melanoma	1.26e-05	6.19e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CG—melanoma	1.24e-05	6.09e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—VEGFA—melanoma	1.23e-05	6.03e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—VEGFA—melanoma	1.23e-05	6.01e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—STAT3—melanoma	1.22e-05	5.97e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—NRAS—melanoma	1.21e-05	5.96e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—VEGFA—melanoma	1.21e-05	5.95e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—STAT3—melanoma	1.21e-05	5.95e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—NRAS—melanoma	1.21e-05	5.94e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—IL6—melanoma	1.21e-05	5.92e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—STAT3—melanoma	1.2e-05	5.89e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—NRAS—melanoma	1.2e-05	5.88e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PPARG—melanoma	1.2e-05	5.88e-05	CbGpPWpGaD
Atropine—CHRM4—Signaling Pathways—AKT1—melanoma	1.16e-05	5.71e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK3—melanoma	1.16e-05	5.71e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK3—melanoma	1.16e-05	5.69e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK3—melanoma	1.15e-05	5.63e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—PIK3CA—melanoma	1.14e-05	5.62e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MYC—melanoma	1.13e-05	5.55e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MYC—melanoma	1.13e-05	5.53e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MYC—melanoma	1.12e-05	5.48e-05	CbGpPWpGaD
Atropine—CHRM5—Signaling Pathways—AKT1—melanoma	1.11e-05	5.47e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—MAPK1—melanoma	1.11e-05	5.43e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—EGFR—melanoma	1.11e-05	5.43e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—MAPK1—melanoma	1.1e-05	5.41e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—EGFR—melanoma	1.1e-05	5.41e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—MAPK1—melanoma	1.09e-05	5.36e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—EGFR—melanoma	1.09e-05	5.36e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CD—melanoma	1.09e-05	5.35e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—ALB—melanoma	1.08e-05	5.28e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—KRAS—melanoma	1.05e-05	5.13e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—KRAS—melanoma	1.04e-05	5.11e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—KRAS—melanoma	1.03e-05	5.06e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—PIK3CA—melanoma	9.6e-06	4.71e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—PIK3CA—melanoma	9.57e-06	4.7e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CB—melanoma	9.51e-06	4.67e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—PIK3CA—melanoma	9.48e-06	4.65e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTGS2—melanoma	9.42e-06	4.62e-05	CbGpPWpGaD
Atropine—CHRM3—Metabolism—AKT1—melanoma	9.35e-06	4.59e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—TP53—melanoma	9.29e-06	4.56e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—TP53—melanoma	9.26e-06	4.54e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—TP53—melanoma	9.17e-06	4.5e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—HRAS—melanoma	8.88e-06	4.36e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—HRAS—melanoma	8.86e-06	4.34e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—HRAS—melanoma	8.77e-06	4.3e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—IL6—melanoma	8.5e-06	4.17e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—IL6—melanoma	8.48e-06	4.16e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—IL6—melanoma	8.39e-06	4.12e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PTEN—melanoma	8.22e-06	4.03e-05	CbGpPWpGaD
Atropine—CHRM1—Signaling Pathways—AKT1—melanoma	7.84e-06	3.85e-05	CbGpPWpGaD
Atropine—CHRM3—Signaling Pathways—AKT1—melanoma	7.82e-06	3.84e-05	CbGpPWpGaD
Atropine—CHRM2—Signaling Pathways—AKT1—melanoma	7.74e-06	3.8e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—PIK3CA—melanoma	5.8e-06	2.84e-05	CbGpPWpGaD
Atropine—CYP1A2—Metabolism—AKT1—melanoma	4.74e-06	2.32e-05	CbGpPWpGaD
